BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: do Espírito Santo GF, Galera BB, Duarte EC, Chen ES, Azis L, Damazo AS, Saba GT, de Sousa Gehrke F, Guerreiro da Silva IDC, Waisberg J. Prognostic significance of vascular endothelial growth factor polymorphisms in colorectal cancer patients. World J Gastrointest Oncol 2017; 9(2): 78-86 [PMID: 28255429 DOI: 10.4251/wjgo.v9.i2.78]
URL: https://www.wjgnet.com/1007-9327/full/v9/i2/78.htm
Number Citing Articles
1
O. A. Babadjanov, H. Ya. Karimov, S. S. Arifov, K. T. Boboev. Evaluation into the Role of the VEGF Gene Polymorphism rs2010963 in the Development of Rosacea and its Relationship with Clinical Subtypes of the DiseaseCytology and Genetics 2019; 53(3): 233 doi: 10.3103/S0095452719030083
2
Md. Abdul Aziz, Mohammad Sarowar Uddin, Md. Shalahuddin Millat, Mohammad Safiqul Islam. Vascular endothelial growth factor A (VEGFA) promoter rs2010963 polymorphism and cancer risk: An updated meta-analysis and trial sequential analysisMeta Gene 2022; 31: 101017 doi: 10.1016/j.mgene.2022.101017
3
Giorgia Marisi, Irene Azzali, Alessandro Passardi, Francesca Rebuzzi, Giulia Bartolini, Milena Urbini, Matteo Canale, Chiara Molinari, Laura Matteucci, Francesco Giulio Sullo, Silvia Angela Debonis, Chiara Gallio, Graziana Gallo, Giovanni Luca Frassineti, Paola Ulivi. Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancerScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-40220-7
4
Hong Wu, Tianjun Ma, Dongli Li, Mei He, Hui Wang, Ying Cui. Circulating vascular endothelial growth factor and cancer risk: A bidirectional mendelian randomizationFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.981032
5
N. García-Romero, I. Palacín-Aliana, R. Madurga, J. Carrión-Navarro, S. Esteban-Rubio, B. Jiménez, A. Collazo, F. Pérez-Rodríguez, A. Ortiz de Mendivil, C. Fernández-Carballal, S. García-Duque, J. Diamantopoulos-Fernández, C. Belda-Iniesta, R. Prat-Acín, P. Sánchez-Gómez, E. Calvo, A. Ayuso-Sacido. Bevacizumab dose adjustment to improve clinical outcomes of glioblastomaBMC Medicine 2020; 18(1) doi: 10.1186/s12916-020-01610-0
6
Mehtap Cevik, Esat Namal, Nur Dinc-Sener, Ulkuhan Iner-Koksal, Cavlan Ciftci, Belgin Susleyici. Investigation of Vascular Endothelial Growth Factor Polymorphisms on Risk, Metastasis, Laterality, and Prognosis of Colorectal Cancer in Turkish SubjectsGenetic Testing and Molecular Biomarkers 2022; 26(5): 298 doi: 10.1089/gtmb.2021.0213
7
Maria Abancens, Viviana Bustos, Harry Harvey, Jean McBryan, Brian J. Harvey. Sexual Dimorphism in Colon CancerFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.607909
8
Martha M. Grimes, S. Ray Kenney, Dayna R. Dominguez, Kathryn J. Brayer, Yuna Guo, Angela Wandinger-Ness, Laurie G. Hudson. The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivoBMC Cancer 2021; 21(1) doi: 10.1186/s12885-020-07716-1
9
Giuseppe Corrias, Eleonora Lai, Pina Ziranu, Stefano Mariani, Clelia Donisi, Nicole Liscia, Giorgio Saba, Andrea Pretta, Mara Persano, Daniela Fanni, Dario Spanu, Francesca Balconi, Francesco Loi, Simona Deidda, Angelo Restivo, Valeria Pusceddu, Marco Puzzoni, Cinzia Solinas, Elena Massa, Clelia Madeddu, Clara Gerosa, Luigi Zorcolo, Gavino Faa, Luca Saba, Mario Scartozzi. Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional ImagingCancers 2024; 16(7): 1364 doi: 10.3390/cancers16071364
10
Reyhaneh Manafi-Farid, Bahar Ataeinia, Shaghayegh Ranjbar, Zahra Jamshidi Araghi, Mohammad Mobin Moradi, Christian Pirich, Mohsen Beheshti. ImmunoPET: Antibody-Based PET Imaging in Solid TumorsFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.916693